Evidence map›Paper›PMID 25211248›Full record

ArticlePloS one2014

1H-NMR metabolomic biomarkers of poor outcome after hemorrhagic shock are absent in hibernators.

Lori K Bogren, Carl J Murphy, Erin L Johnston, Neeraj Sinha, Natalie J Serkova, Kelly L Drew

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Formulation insights into competitive binding of NJournal of pharmaceutical and biomedical analysis · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lori K BogrenDepartment of Chemistry and Biochemistry, University of Alaska Fairbanks, Fairbanks, AK, United States of America; Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, United States of America.
Carl J MurphyDepartment of Chemistry and Biochemistry, University of Alaska Fairbanks, Fairbanks, AK, United States of America.
Erin L JohnstonDepartment of Chemistry and Biochemistry, University of Alaska Fairbanks, Fairbanks, AK, United States of America.
Neeraj SinhaCentre of Biomedical Research, SGPGIMS Campus, Lucknow, Uttar Pradesh, India.
Natalie J SerkovaDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.
Kelly L DrewDepartment of Chemistry and Biochemistry, University of Alaska Fairbanks, Fairbanks, AK, United States of America; Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, United States of America.
University of Alaska Fairbanks · USSanjay Gandhi Post Graduate Institute of Medical Sciences · INUniversity of Colorado Anschutz Medical Campus · US

Funding

The Administrative CoreP20GM103395 · NIGMS · UNIVERSITY OF ALASKA FAIRBANKS · PI BRIAN M BARNES · 2012 to 2026
$66.1M
Targeting Central A1 Adenosine Receptors Induces Hypothermia for StrokeR15NS070779 · NINDS · UNIVERSITY OF ALASKA FAIRBANKS · PI DREW, KELLY L · 2010 to 2014
$949k
NIGMS NIH HHS P20 GM103395NINDS NIH HHS R15 NS070779
6 · The paper itself

Abstract

backgroundHemorrhagic shock (HS) following trauma is a leading cause of death among persons under the age of 40. During HS the body undergoes systemic warm ischemia followed by reperfusion during medical intervention. Ischemia/reperfusion (I/R) results in a disruption of cellular metabolic processes that ultimately lead to tissue and organ dysfunction or failure. Resistance to I/R injury is a characteristic of hibernating mammals. The present study sought to identify circulating metabolites in the rat as biomarkers for metabolic alterations associated with poor outcome after HS. Arctic ground squirrels (AGS), a hibernating species that resists I/R injury independent of decreased body temperature (warm I/R), was used as a negative control. METHODOLOGY/PRINCIPAL

findingsMale Sprague-Dawley rats and AGS were subject to HS by withdrawing blood to a mean arterial pressure (MAP) of 35 mmHg and maintaining the low MAP for 20 min before reperfusing with Ringers. The animals' temperature was maintained at 37 ± 0.5 °C for the duration of the experiment. Plasma samples were taken immediately before hemorrhage and three hours after reperfusion. Hydrophilic and lipid metabolites from plasma were then analyzed via 1H-NMR from unprocessed plasma and lipid extracts, respectively. Rats, susceptible to I/R injury, had a qualitative shift in their hydrophilic metabolic fingerprint including differential activation of glucose and anaerobic metabolism and had alterations in several metabolites during I/R indicative of metabolic adjustments and organ damage. In contrast, I/R injury resistant AGS, regardless of season or body temperature, maintained a stable metabolic homeostasis revealed by a qualitative 1H-NMR metabolic profile with few changes in quantified metabolites during HS-induced global I/R. CONCLUSIONS/SIGNIFICANCE: An increase in circulating metabolites indicative of anaerobic metabolism and activation of glycolytic pathways is associated with poor prognosis after HS in rats. These same biomarkers are absent in AGS after HS with warm I/R.

Indexed as

MetabolomeAnimalsBiomarkersHibernationLipidsMagnetic Resonance SpectroscopyMaleRats, Sprague-DawleyReperfusion InjurySciuridaeShock, HemorrhagicTreatment OutcomeBiomarkersLipids

Identifiers

PMID25211248
PMCPMC4161479
OpenAlexW1972527094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.